Latest News

06/29/2022 - 09:47

LAMPIRE @ AACC 2022

AACC 2022 (July 24-28) is in Chicago this year and LAMPIRE Biological Labs will be there in person!  LAMPIRE will be fully staffed at two convenient locations, 3305 and 3041.  We look forward to reconnecting and seeing how we can help you meet your research needs in 2022 and beyond.  It’s never too early to start planning so click the link below to set up an in person or virtual meeting.

06/02/2022 - 09:19

LAMPIRE Celebrates Founder's Day

On Wednesday, LAMPIRE will be Celebrating the Birthday of Craig Tarler.  

Craig was vital in the creation of LAMPIRE, thus declaring June 2nd Founder’s Day.  

Since 1977 LAMPIRE has been supplying biological raw materials to the Life Sciences Industry!

06/01/2022 - 16:56

Price Change Notification

Dear Valued Customer,

First and foremost, thank you for being a Lampire customer. For 45 years Lampire has played an important role as a key supplier of critical raw materials.  We continue our mission to make your research goals our top priority and are grateful for the trust you place with us. We also recognize that we are all being impacted by inflation in ways we have not seen for decades.

06/01/2022 - 15:16

LAMPIRE Celebrates Its 45th Anniversary

In celebration of the company's years of supporting the Life Science community, LAMPIRE celebrates its 45th anniversary. LAMPIRE is an international, life science company that produces biological reagents and raw materials that are shipped worldwide and used across many applications. Servicing the diagnostic, pharmaceutical, biotechnology and drug discovery markets for over 45 years LAMPIRE is a trusted partner for high quality, reliable products, and services.

06/01/2022 - 15:01

June Feature Item: Llama Custom Antibody Services

With one of the most unique immune systems, many researchers are hoping Llamas will be key to finding cures to our most common threatening diseases.  Llamas have unique heavy chain only antibodies that bind to epitopes and are inaccessible to traditional antibodies.  They have a longer shelf-life, higher tolerance to extreme conditions, and a higher pH.  Recombinant “nanobodies”, or antigen-binding single domain proteins are easily engineered from llama antibody genes.   

04/26/2022 - 12:11

PRESS RELEASE: LAMPIRE BIOLOGICAL LABORATORIES SPEAKS AT THE SPRING INFORMATIONAL

LAMPIRE Biological Laboratories, was honored to be the keynote speaker at the Spring Informational Meeting for the Bedford Farm Bureau held in Bedford PA.

04/14/2022 - 11:42

Press Release: LAMPIRE Biological Laboratories Attends The Annual Advocacy Day Organized By Life Sciences PA In Harrisburg, Pennsylvania

LAMPIRE Biological Laboratories recently accepted an invitation to attend the annual Advocacy Day organized by Life Sciences PA in Harrisburg, Pennsylvania.

04/11/2022 - 09:09

Llamas Custom Antibody Services

With one of the most unique immune systems, many researchers are hoping Llamas will be key to finding cures to our most common threatening diseases.  Llamas have unique heavy chain only antibodies that bind to epitopes and are inaccessible to traditional antibodies.  They have a longer shelf-life, higher tolerance to extreme conditions, and a higher pH.  Recombinant “nanobodies”, or antigen-binding single domain proteins are easily engineered from llama antibody genes.   

03/04/2022 - 09:11

LAMPIRE’s Preventative Response Measures Avian Influenza

Due to the worldwide focus and attention on avian influenza, also known as "bird flu", we would like to assure you of LAMPIRE Biological Laboratories current preventative bird health programs and activities.

02/07/2022 - 13:00

Rabbit Polyclonal Antibody Services

Rabbits are used for polyclonal and/or recombinant monoclonal antibody production. Rabbits have a high success rate across a broad range of immunogens, including haptens and human antigens, due to their phylogenetic distance from most animal research models. LAMPIRE has extensive experience with rabbits as an animal model, therefore our standard production protocols are well developed and documented to produce high affinity antibodies.